Location History:
- Standford, CA (US) (2007)
- Standord, CA (US) (2009)
Company Filing History:
Years Active: 2007-2009
Title: Hanbiao Yang: Innovator in CCR5 Antagonist Research
Introduction
Hanbiao Yang is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target CCR5-related diseases. With a total of 3 patents to his name, Yang's work is pivotal in advancing treatments for serious health conditions.
Latest Patents
Among his latest patents, Yang has developed indane compounds as CCR5 antagonists. These compounds are designed to inhibit HIV replication and are useful in the prevention or treatment of HIV infections. Furthermore, they play a crucial role in addressing the resulting acquired immune deficiency syndrome (AIDS). His innovative approach to these compounds showcases his commitment to improving health outcomes for individuals affected by these diseases.
Career Highlights
Hanbiao Yang is currently associated with SmithKline Beecham Corporation, where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients.
Collaborations
Yang has collaborated with esteemed colleagues such as Wieslaw Mieczyslaw Kazmierski and Christopher Joseph Aquino. These partnerships highlight the collaborative nature of research and innovation in the pharmaceutical industry.
Conclusion
In summary, Hanbiao Yang is a distinguished inventor whose work in CCR5 antagonists is making a significant impact in the fight against HIV and AIDS. His contributions to the field are invaluable and continue to inspire future innovations in healthcare.